Skip to main navigation Skip to search Skip to main content

Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy

  • Kazuko Kudo
  • , Asahito Hama
  • , Seiji Kojima
  • , Ruriko Ishii
  • , Akira Morimoto
  • , Fumio Bessho
  • , Shosuke Sunami
  • , Naoyuki Kobayashi
  • , Akitoshi Kinoshita
  • , Yuri Okimoto
  • , Akio Tawa
  • , Ichiro Tsukimoto

Research output: Contribution to journal › Article › peer-review

19   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science